Moleculin Biotech Inc (MBRX : NASDAQ)
Common Stock
$5.26
USD
+4.98 (1775.89%)
Last updated: 2026-10-19
Follow MBRX
MBRX
Moleculin Biotech Inc
WealthAwesomePerformance
1 Day
+1775.89%
1 Week
+1170.84%
1 Month
+580.47%
YTD
+87.86%
Key Statistics
Market Cap
$5.72M
52W High
$315.00
52W Low
$3.23
P/E Ratio
0.03
50 Day MA
$0.58
200 Day MA
$2.20
Beta
2.00
Dividend Yield
-
Advertisement
Technical Indicators
Price vs 50-Day SMA
Price vs 200-Day SMA
Recent Price History
| Date | Open | High | Low | Close | Adj Close | Volume |
|---|---|---|---|---|---|---|
| 10/19/2026 | $5.60 | $5.60 | $4.42 | $5.26 | $5.26 | 53,084 |
| 10/16/2026 | $0.31 | $0.33 | $0.28 | $0.28 | $0.28 | 1,188,461 |
| 10/15/2026 | $0.42 | $0.43 | $0.37 | $0.37 | $0.37 | 326,473 |
| 10/14/2026 | $0.44 | $0.44 | $0.41 | $0.41 | $0.41 | 273,657 |
| 10/13/2026 | $0.42 | $0.44 | $0.41 | $0.44 | $0.44 | 183,471 |
| 10/12/2026 | $0.45 | $0.45 | $0.41 | $0.41 | $0.41 | 171,092 |
| 10/9/2026 | $0.42 | $0.46 | $0.41 | $0.44 | $0.44 | 341,000 |
| 10/8/2026 | $0.44 | $0.44 | $0.41 | $0.42 | $0.42 | 263,610 |
| 10/7/2026 | $0.46 | $0.46 | $0.43 | $0.44 | $0.44 | 425,346 |
| 10/6/2026 | $0.49 | $0.49 | $0.44 | $0.45 | $0.45 | 705,893 |
Analyst Price Targets
Based on 3 analysts covering MBRX · as of Oct 5, 2026
Wall Street analysts forecast MBRX stock price to rise 128.1% over the next 12 months.
Consensus
Strong Buy4.67 / 5.00
Avg. Target
US$12.00
+128.1% Upside
Current Price
US$5.26
Last close
Analyst Breakdown (3 analysts)
Targets are snapshotted when they change. Unchanged figures keep their original date. Not financial advice.
Wealth Awesome Price Forecast
WA ModelStatistical 90-day price range based on MBRX's historical volatility
30-Day Vol
874.5%
Annualized
90-Day Vol
556.9%
Annualized
Trend (90d)
+50.0%
Annualized drift
90d Mean
US$6.29
Expected price
| Horizon | Expected | 68% Range (1σ) |
|---|---|---|
| 30 trading days | US$5.58 | US$0.27 – US$114.08 |
| 60 trading days | US$5.92 | US$0.08 – US$422.49 |
| 90 trading days | US$6.29 | US$0.03 – US$1169.91 |
Methodology: Range is calculated using 30-day realized volatility via geometric Brownian motion (log-normal model). 68% band = ±1σ, 95% band = ±2σ. This is a statistical model, not a prediction. Past volatility does not guarantee future results. Not financial advice.
About Moleculin Biotech Inc
Moleculin Biotech, Inc., a late-stage pharmaceutical development company, engages in the development of therapeutic candidates for the treatment of tumors and viruses. Its lead drug candidate is Annamycin, an anthracycline, which is in clinical stage for the treatment of relapsed or refractory acute myeloid leukemia and soft tissue sarcoma lung metastases. The company is also developing WP1066 portfolio, including WP1066, WP1193, and WP1220, which are immune/transcription modulators designed to inhibit phosphorylated signal transducer and activator of transcription for brain tumors and pancreatic and other cancers. In addition, it is developing WP1122 portfolio, such as WP1122, WP1096, and WP1097 designed to exploit the uses of inhibitors of glycolysis comprising 2-deoxy-D-glucose that cut off the energy supply of tumors. The company was incorporated in 2015 and is headquartered in Houston, Texas.
Financials
- Revenue (TTM)
- $0
- EBITDA
- $-28.83M
- Profit Margin
- 0.00%
- ROE (TTM)
- -1371.64%
- EPS (Diluted)
- 8.98
- Book Value
- 1.63
Classification
- Sector
- Health Care
- Industry
- Biotechnology
- Group
- Pharmaceuticals, Biotechnology & Life Sciences
7 stocks to buy and hold forever
Blue-chip dividend stocks for long-term wealth building.
Get the FREE ReportExplore More
Advertisement
Common Questions About MBRX.US
Market movers
Recent NASDAQ movers
Top 1-day gainers — updated from our Canadian movers feed.
| Ticker | Name | Price | 1D |
|---|---|---|---|
| FRGT | Freight Technologies Inc | $1.47 | +97900.00% |
| GP | GreenPower Motor Company Inc | $1.46 | +11217.83% |
| REVB | Revelation Biosciences Inc | $3.29 | +577.76% |
| SLN | Silence Therapeutics PLC | $19.58 | +125.58% |
| SXTC | China SXT Pharmaceuticals Inc | $0.11 | +71.08% |
| AFJKR | Aimei Health Technology Co., Ltd Right | $0.14 | +64.47% |
| XHG | XChange TEC.INC | $3.20 | +60.00% |
| SOBR | Sobr Safe Inc | $0.07 | +39.81% |